Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New procedure codes in Finland from January 2025

In September 2024, the Finnish classification of procedures (THL) was updated two times. On September 6, 2024, seven new procedure codes concerning mental health and dental procedures were introduced. On September 11, 2024, forty new procedure codes concerning gastrointestinal, obstetrics and gynecology, surgical procedures, and some other fields were introduced. The codes will come into force on January 1, 2025. Some examples of new codes are listed below:

  • SJE04 Bite balancing at the end of orthodontic treatment;
  • JFB48 Partial colectomy with the connection of the ileum to the sigmoid colon;
  • LAF02 Removal of the fallopian tube and ovary through the vagina;
  • PJA13 Targeted lymphadenectomy;
  • WB135 Adjuvant treatment of a primary tumor with two or more protein kinase inhibitors;
  • WPA17 Early palliative care intervention;
  • WZA40 Fall risk assessment.

See the full details in Finnish here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.